Page last updated: 2024-08-25

rosiglitazone and atrial natriuretic factor

rosiglitazone has been researched along with atrial natriuretic factor in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asakawa, M; Hasegawa, H; Kadowaki, T; Komuro, I; Kubota, N; Masuda, Y; Nagai, T; Saito, T; Takano, H; Uozumi, H1
Duan, SZ; Ivashchenko, CY; Milstone, DS; Mortensen, RM; Russell, MW1
Amstutz, C; Cotecchia, S; Darimont, C; Garruti, G; Giorgino, F; Giorgino, R; Giusti, V; Nussberger, J; Puglisi, F; Verdumo, C1
Goenka, N; Kotonya, C; O'Hare, JP; Penney, MD; Randeva, HS1
Achouba, A; Arsenault, M; Brûlé, S; Couet, J; Deshaies, Y; Festuccia, WT; Guerra-Sá, R; Houde, VP; Lachance, D; Laplante, M; Marette, A; Pedrosa, ML; Silva, ME1
Cha, SA; Gao, S; Kim, SH; Kim, SZ; Park, BM1
Al Yacoub, N; Awad, SM; El-Orabi, NF; Kunhi, M; Pharaon, LF; Poizat, C1
Abassi, Z; Aronson, D; Feuerstein, GZ; Goltsman, I; Khoury, EE; Nativ, O; Winaver, J1

Trials

1 trial(s) available for rosiglitazone and atrial natriuretic factor

ArticleYear
Thiazolidinediones and the renal and hormonal response to water immersion-induced volume expansion in type 2 diabetes mellitus.
    American journal of physiology. Endocrinology and metabolism, 2008, Volume: 294, Issue:4

    Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Diabetes Mellitus, Type 2; Homeostasis; Humans; Hypoglycemic Agents; Immersion; Kidney; Male; Middle Aged; Natriuresis; Renin; Rosiglitazone; Thiazolidinediones; Water-Electrolyte Imbalance

2008

Other Studies

7 other study(ies) available for rosiglitazone and atrial natriuretic factor

ArticleYear
Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
    Circulation, 2002, Mar-12, Volume: 105, Issue:10

    Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cell Size; Cells, Cultured; Chromans; Disease Models, Animal; Gene Expression; Heart; Heterozygote; Hypoglycemic Agents; Ligands; Mice; Mice, Knockout; Myocardium; Organ Size; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

2002
Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
    Circulation research, 2005, Aug-19, Volume: 97, Issue:4

    Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Myocytes, Cardiac; Myosin Heavy Chains; NF-kappa B; Phosphorylation; PPAR gamma; Rosiglitazone; Systole; Thiazolidinediones

2005
Expression and secretion of the atrial natriuretic peptide in human adipose tissue and preadipocytes.
    Obesity (Silver Spring, Md.), 2007, Volume: 15, Issue:9

    Topics: Adipocytes; Adipose Tissue; Adult; Atrial Natriuretic Factor; Cell Line; Female; Gene Expression Regulation; Humans; Ion Channels; Microscopy, Fluorescence; Mitochondrial Proteins; Peptides; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA; Rosiglitazone; Serine Endopeptidases; Thiazolidinediones; Uncoupling Protein 1

2007
Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation.
    Journal of molecular and cellular cardiology, 2009, Volume: 47, Issue:1

    Topics: Animals; Atrial Natriuretic Factor; Blotting, Western; Body Weight; Cardiomegaly; Eating; Echocardiography; Glucosyltransferases; Glycogen; Glycogen Phosphorylase; Glycogen Synthase; Glycoproteins; Hemodynamics; Hypoglycemic Agents; Lipoprotein Lipase; Male; Myofibrils; Natriuretic Peptide, Brain; Proteasome Endopeptidase Complex; Protein Kinases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; TOR Serine-Threonine Kinases; UTP-Glucose-1-Phosphate Uridylyltransferase

2009
Comparision of secretagogue effects of rosiglitazone and telmisartan on ANP secretion in rats.
    Peptides, 2014, Volume: 56

    Topics: Animals; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Male; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Rosiglitazone; Telmisartan; Thiazolidinediones

2014
Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes.
    Toxicology letters, 2017, Oct-05, Volume: 280

    Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Chromatin Assembly and Disassembly; Epigenesis, Genetic; Female; Fibrinolytic Agents; Gene Expression Regulation; Histones; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2017
Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:7

    Topics: Acetylcholine; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Endothelium; Gene Expression Regulation; Heart Failure; Hemodynamics; Kidney; Male; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Vasodilation

2019